GlassScriptPhysician profile
Dorene Marinese
NPI 1841424009
$3,684.48
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,713 · 2020: $817 · 2021: $769 · 2022: $107 · 2023: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $278.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celularity INC. | $1,800.00 | 2019-2021 | |
| Gen-Probe, INC. | $557.78 | 2019 | |
| Abbvie INC. | $266.51 | 2019-2023 | |
| Pfizer INC. | $175.18 | 2019-2023 | |
| Lupin INC. | $158.59 | 2019-2020 | |
| Coopersurgical, INC. | $125.80 | 2019-2023 | Paragard T 380a |
| Roche Diagnostics Corporation | $107.03 | 2019 | |
| Therapeuticsmd, INC. | $94.95 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $91.63 | 2019-2020 | |
| Organon LLC | $68.49 | 2022-2023 | Nexplanon |
| Hologic Sales and Service, LLC | $48.67 | 2021-2023 | Aptima, Thinprep 2000 Processor |
| Allergan, INC. | $34.43 | 2019 | |
| Vertical Pharmaceuticals, LLC | $32.68 | 2019 | |
| Avion Pharmaceuticals | $21.20 | 2021 | |
| Zimmer Biomet Holdings, INC. | $19.81 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $19.09 | 2019 | |
| Merck Sharp & Dohme LLC | $16.37 | 2019 | |
| Myovant Sciences INC. | $16.35 | 2021 | |
| Mayne Pharma Commercial LLC | $15.21 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.71 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dorene Marinese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.